BIOA vs. ORMP
BIOA (BioAge Labs, Inc) and ORMP (Oramed Pharmaceuticals Inc.) are both stocks. Both are in the Healthcare sector — BIOA in Drug Manufacturers - Specialty & Generic, ORMP in Biotechnology. Over the past year, BIOA returned 414.29% vs 111.99% for ORMP. At a 0.15 correlation, their price movements are largely independent.
Performance
BIOA vs. ORMP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIOA achieves a 68.71% return, which is significantly higher than ORMP's 56.95% return.
BIOA
- 1D
- 3.96%
- 1M
- 34.38%
- YTD
- 68.71%
- 6M
- 68.96%
- 1Y
- 414.29%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ORMP
- 1D
- 3.99%
- 1M
- 4.51%
- YTD
- 56.95%
- 6M
- 51.63%
- 1Y
- 111.99%
- 3Y*
- 11.23%
- 5Y*
- -20.56%
- 10Y*
- -5.81%
BIOA vs. ORMP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
BIOA BioAge Labs, Inc | 68.71% | 128.50% | -74.27% |
ORMP Oramed Pharmaceuticals Inc. | 56.95% | 17.77% | 1.26% |
Correlation
The correlation between BIOA and ORMP is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Sep 26, 2024 | 0.15 |
Fundamentals
BIOA:
$948.16M
ORMP:
$175.02M
BIOA:
-$2.40
ORMP:
$2.86
BIOA:
2.50
ORMP:
0.73
BIOA:
$10.32M
ORMP:
$0.00
BIOA:
$7.48M
ORMP:
$0.00
BIOA:
-$95.08M
ORMP:
$67.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIOA vs. ORMP — Risk / Return Rank
BIOA
ORMP
BIOA vs. ORMP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BioAge Labs, Inc (BIOA) and Oramed Pharmaceuticals Inc. (ORMP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIOA | ORMP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.83 | ||
| Sortino ratioReturn per unit of downside risk | +1.78 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.35 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 12.63 | 4.71 | +7.91 |
| Martin ratioReturn relative to average drawdown | 29.69 | 12.20 | +17.48 |
Loading charts...
Drawdowns
BIOA vs. ORMP - Drawdown Comparison
The maximum BIOA drawdown since its inception was -88.23%, smaller than the maximum ORMP drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for BIOA and ORMP.
Loading charts...
Drawdown Indicators
| BIOA | ORMP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.23% | -94.25% | +6.02% |
Max Drawdown (1Y)Largest decline over 1 year | -33.07% | -23.89% | -9.18% |
Max Drawdown (3Y)Largest decline over 3 years | — | -52.63% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -94.25% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -94.25% | — |
Current DrawdownCurrent decline from peak | -13.59% | -84.96% | +71.37% |
Average DrawdownAverage peak-to-trough decline | -57.48% | -70.78% | +13.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.04% | 9.21% | +4.83% |
Volatility
BIOA vs. ORMP - Volatility Comparison
BioAge Labs, Inc (BIOA) has a higher volatility of 20.35% compared to Oramed Pharmaceuticals Inc. (ORMP) at 15.66%. This indicates that BIOA's price experiences larger fluctuations and is considered to be riskier than ORMP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIOA | ORMP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.35% | 15.66% | +4.69% |
Volatility (6M)Calculated over the trailing 6-month period | 63.14% | 39.15% | +23.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.31% | 51.53% | +31.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 99.79% | 81.05% | +18.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.79% | 71.94% | +27.85% |
Dividends
BIOA vs. ORMP - Dividend Comparison
BIOA has not paid dividends to shareholders, while ORMP's dividend yield for the trailing twelve months is around 6.00%.
| Position | TTM |
|---|---|
BIOA BioAge Labs, Inc | 0.00% |
ORMP Oramed Pharmaceuticals Inc. | 6.00% |
Financials
BIOA vs. ORMP - Financials Comparison
This section allows you to compare key financial metrics between BioAge Labs, Inc and Oramed Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BIOA and ORMP have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIOA has higher volatility (20.35%) compared to ORMP (15.66%). In terms of maximum drawdown, BIOA dropped -88.23% vs ORMP's -94.25%.
BIOA currently has the higher Sharpe Ratio (5.01 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIOA and ORMP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer